Tetracaine Hydrochloride from Chenghui Shuangda Pharm

Established in 2014, Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. is a leading Chinese manufacturer of active pharmaceutical ingredients (APIs) and advanced intermediates. The company operates 6 cGMP-compliant workshops and 9 automated production lines, delivering a monthly production capacity of 100 metric tons. To date, it has filed 22 products with the Center for Drug Evaluation (CDE) in China, registered 4 APIs in the United States Drug Master File (US-DMF), and submitted 7 applications for Certificates of Suitability (CEP) with the European Directorate for the Quality of Medicines (EDQM)‌.Supported by over 100 patents encompassing advanced synthesis and crystallization technologies‌, the company specializes in API manufacturing and offers integrated CDMO (Contract...

Read full company description
Address: Economic Development Zone ,Pingyuan County, Dezhou City, 253100, Shandong Province
China
China Local time:

23 years of production experience

6 workshops and 9 production lines which has 100t/month production capacity

4 USDMFS & 5 CEPS & 200+ Patents

Our clients:

All API Buyers

Our services:

API
Intermediates
Fine Chemicals
R&D Products
CMO/CDMO

Response time:

Produced in:

China

MOQ: -

  • CoA

  • GMP

  • CEP

  • WC

  • MSDS

  • BSE/TSE

Contact supplier

Replies quickly

Chenghui Shuangda Pharm Tetracaine Hydrochloride API Producer - 136-47-0

Description:
Chenghui Shuangda Pharm offers high-quality Tetracaine Hydrochloride API, certified for compliance with international standards. Manufactured in China. 23 years of production experience. 6 workshops and 9 production lines which has 100t/month production capacity. 4 USDMFS & 5 CEPS & 200+ Patents.

Product Details

Certifications
CoA, GMP, CEP, WC, MSDS, BSE/TSE compliant
Minimum Order Quantity
1 kg
Produced in
China (Asia)
CAS Number
136-47-0

Ordering Process

1. Inquiry Submission: Click "Send Inquiry" to connect directly with producer.

2. Requirement Specification: Outline your needs for tailored offers.

3. Quotation: Receive the best quote and terms exclusively through Pharmaoffer.

Additional Products

We offer 92 other Active Pharmaceutical Ingredients and excipients, showcasing our production and distribution capabilities.

Contact Us

Are you looking for Tetracaine Hydrochloride API? Contact Chenghui Shuangda Pharm by using the send inquiry button. We will respond quickly with pricing and terms exclusively through Pharmaoffer.

Please, provide enough information regarding your inquiry. Let us know whether you require Ph.Eur (EP), USP, BP, JP grade, whether you are looking for hydrochloride (HCl), base, or other specific product specifications. Additionally, please inform us if the API is intended for your own production, resale, or research purposes. Contact us to receive a quote, download certificates, and purchase the Tetracaine Hydrochloride API

Chenghui Shuangda Pharm


Established in 2014, Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. is a leading Chinese manufacturer of active pharmaceutical ingredients (APIs) and advanced intermediates. The company operates 6 cGMP-compliant workshops and 9 automated production lines, delivering a monthly production capacity of 100 metric tons. To date, it has filed 22 products with the Center for Drug Evaluation (CDE) in China, registered 4 APIs in the United States Drug Master File (US-DMF), and submitted 7 applications for Certificates of Suitability (CEP) with the European Directorate for the Quality of Medicines (EDQM)‌.Supported by over 100 patents encompassing advanced synthesis and crystallization technologies‌, the company specializes in API manufacturing and offers integrated CDMO (Contract Development and Manufacturing Organization) and CRO (Contract Research Organization) collaborations. Its vertically integrated R&D and production platform underscores robust technical capabilities in delivering high-value .

 Business Scope:

Supply of APIs and intermediates
Co-development of APIs and intermediates
Custom synthesis of new products
CDMO business undertaking